- Service Name
Shield™ Blood Test
- Industry
Healthcare, Oncology, Precision Medicine, Cancer Screening
- Main Value Proposition
The Shield™ Blood Test offers a convenient and effective method for early detection of colon cancer, improving patient outcomes through timely intervention.
- Description
The Shield™ Blood Test is the first FDA-approved blood test for colon cancer, designed to be administered during any healthcare visit. It provides a more pleasant and accessible way for patients to screen for colon cancer, covered by Medicare.
- Key Features
FDA-approved for colon cancer screening; Can be administered at any healthcare visit; Covered by Medicare; Provides insights for patients at all stages of the disease
- Use Cases
The Shield™ Blood Test is most valuable for patients seeking a non-invasive method to screen for colon cancer, healthcare providers looking for effective screening options, and biopharma companies interested in patient data for treatment development.
- Competitive advantages
First FDA-approved blood test for colon cancer; Convenient screening process at any healthcare visit; Medicare coverage enhances accessibility for patients
- Strengths
Guardant Health leverages advanced data analytics and precision medicine to provide innovative cancer screening solutions, significantly improving the standard of care.
- Positioning
Guardant Health positions itself as a leader in precision oncology, focusing on data-driven solutions that enhance cancer care and patient outcomes.
- Audience
The primary target users include cancer patients, healthcare providers, and biopharma companies, with maximum value for those seeking innovative cancer screening solutions.
- Brand Positioning
Guardant Health is identified as a pioneering company in precision medicine, dedicated to transforming cancer care through innovative blood tests and data analytics.
- CTA
Learn More
- Differentiation
Shield™ stands out as the first blood test for colon cancer that is FDA-approved and covered by Medicare, making it a unique offering in the market.
- Tagline
Shield™ Is Finally Here
- Tags
Blood Test
Colon Cancer
Precision Oncology
FDA Approved
- Tone of Voice
Innovative, compassionate, authoritative
- Founded
2012-01-01
- Founders
AmirAli Talasaz
Helmy Eltoukhy